Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation-Reference-Cited by-同舟云学术

Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation

Published:2023-06-15 Issue:3 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Siopi Maria¹,Peroukidou Ilektra¹,Beredaki Maria-Ioanna¹,Spruijtenburg Bram²³,de Groot Theun²³,Meis Jacques F.²³^ORCID,Vrioni Georgia⁴,Tsakris Athanasios⁴^ORCID,Pournaras Spyros¹,Meletiadis Joseph¹^ORCID

Affiliation:

1. Clinical Microbiology Laboratory, “Attikon” University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

2. Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

3. Centre of Expertise in Mycology, Radboud University Medical Center/Canisius Wilhelmina Hospital, Nijmegen, The Netherlands

4. Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Abstract

Candida auris is an emerging and frequently multidrug-resistant fungal pathogen that accounts for life-threatening invasive infections and nosocomial outbreaks worldwide. Reliable AF is important for the choice of the optimal treatment.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.04431-22

Reference31 articles.

1. So Many Diagnostic Tests, So Little Time: Review and Preview of Candida auris Testing in Clinical and Public Health Laboratories

2. In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris

3. Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019

4. Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria

5. Antifungal Susceptibility Testing and Identification

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China;Emerging Microbes & Infections;2024-09-09

2. Amphotericin B and micafungin duo-loaded nanoemulsion as a potential strategy against Candida auris biofilms;Biofouling;2024-09-08

3. Evaluation of Etest and MICRONAUT-AM Assay for Antifungal Susceptibility Testing of Candida auris: Underestimation of Fluconazole Resistance by MICRONAUT-AM and Overestimation of Amphotericin B Resistance by Etest;Antibiotics;2024-09-04

4. Genotypic and phenotypic characterisation of a nosocomial outbreak of Candida auris in Spain during 5 years;Mycoses;2024-07-31

5. The Micronaut–AM antifungal susceptibility testing method does not overestimate amphotericin B resistance in Candida auris;Microbiology Spectrum;2024-05-02